poisar

Stocks · News reference

'TPG Working With JPMorgan Chase Bankers To Explore Potential $5 Billion Sale Of Healthcare Payments Software Firm Lyric, Sources Said' - Reuters Exclusive

Benzinga Newsdesk

TPG is working with JPMorgan on possible Lyric sale, sources saidLyric generates about $250 million of annual EBITDA, sources saidInsurers including UnitedHealth, CVS and Humana hire Lyric to prevent inaccurate medical

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

JPMTPG
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  3. Scott Levine

    Why Corteva Stock Is Rocketing Higher Today

    Corteva stock surged 12.99% following JPMorgan's upgrade to overweight with a $19 price target, implying 53.3% upside from the previous closing price of $12.39. The upgrade comes after Corteva's October spinoff of its advanced seed and genetics business, with JPMorgan believing the company is now undervalued. The crop protection segment has shown strong growth, with over $1 billion in sales increases and 250 basis points of margin expansion from 2020-2025.

    CTVAAMJBJPMJPMPCJPMPD